{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:50:04Z","timestamp":1790520604426,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T00:00:00Z","timestamp":1591142400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T00:00:00Z","timestamp":1591142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["031B0098C"],"award-info":[{"award-number":["031B0098C"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["031B0098C"],"award-info":[{"award-number":["031B0098C"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["031B0098C"],"award-info":[{"award-number":["031B0098C"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["031B0098C"],"award-info":[{"award-number":["031B0098C"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["031B0098C"],"award-info":[{"award-number":["031B0098C"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["031B0098C"],"award-info":[{"award-number":["031B0098C"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["031B0098C"],"award-info":[{"award-number":["031B0098C"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["031B0098C"],"award-info":[{"award-number":["031B0098C"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Acute lymphoblastic leukaemia (ALL) is the most common form of paediatric cancer and epigenetic aberrations are determinants of leukaemogenesis. The aim of this study was to investigate the methylation degree of a distinct phospholipase A2 receptor 1 (PLA2R1) promoter region in paediatric ALL patients and to evaluate its relevance as new biomarker for monitoring treatment response and burden of residual disease. The impact of PLA2R1 re-expression on proliferative parameters was assessed <jats:italic>in vitro<\/jats:italic> in Jurkat cells with <jats:italic>PLA2R1<\/jats:italic> naturally silenced by DNA methylation. Genomic DNA was isolated from bone marrow (BM) and peripheral blood (PB) of 44 paediatric ALL patients. <jats:italic>PLA2R1<\/jats:italic> methylation was analysed using digital PCR and compared to 20 healthy controls. Transfected Jurkat cells were investigated using cell growth curve analysis and flow cytometry. <jats:italic>PLA2R1<\/jats:italic> was found hypermethylated in BM and PB from pre-B and common ALL patients, and in patients with the disease relapse. <jats:italic>PLA2R1<\/jats:italic> methylation decreased along with leukaemic blast cell reduction during ALL induction treatment. <jats:italic>In vitro<\/jats:italic> analysis revealed an anti-proliferative phenotype associated with PLA2R1 re-expression, suggesting a tumour-suppressive function of PLA2R1. Collected data indicates that <jats:italic>PLA2R1<\/jats:italic> promoter methylation quantitation can be used as biomarker for ALL induction treatment control, risk stratification, and early detection of ALL relapse.<\/jats:p>","DOI":"10.1038\/s41598-020-65825-0","type":"journal-article","created":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T15:01:45Z","timestamp":1591196505000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Methylation of the Phospholipase A2 Receptor 1 Promoter Region in Childhood B Cell Acute Lymphoblastic Leukaemia"],"prefix":"10.1038","volume":"10","author":[{"given":"Markus","family":"Friedemann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Gutewort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Thiem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brit","family":"Nacke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Jandeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn S\u00f6nke","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1041-3311","authenticated-orcid":false,"given":"Olga","family":"Sukocheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9522-8838","authenticated-orcid":false,"given":"Meinolf","family":"Suttorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Menschikowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,3]]},"reference":[{"key":"65825_CR1","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S1470-2045(17)30186-9","volume":"18","author":"E Steliarova-Foucher","year":"2017","unstructured":"Steliarova-Foucher, E. et al. International incidence of childhood cancer, 2001\u201310. A population-based registry study. The Lancet Oncology 18, 719\u2013731 (2017).","journal-title":"The Lancet Oncology"},{"key":"65825_CR2","unstructured":"Noone A. M. et al (eds). SEER Cancer Statistics Review. Available at https:\/\/seer.cancer.gov\/csr\/1975_2015\/ (1975\u20132015)."},{"key":"65825_CR3","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.1002\/jcp.26510","volume":"234","author":"R Ranjbar","year":"2019","unstructured":"Ranjbar, R. et al. The importance of miRNAs and epigenetics in acute lymphoblastic leukemia prognosis. Journal of cellular physiology 234, 3216\u20133230 (2019).","journal-title":"Journal of cellular physiology"},{"key":"65825_CR4","doi-asserted-by":"crossref","unstructured":"Gatta, G. et al. Rare cancers are not so rare. The rare cancer burden in Europe. European journal of cancer (Oxford, England: 1990) 47, 2493\u20132511; (2011).","DOI":"10.1016\/j.ejca.2011.08.008"},{"key":"65825_CR5","first-page":"83","volume":"64","author":"E Ward","year":"2014","unstructured":"Ward, E., DeSantis, C., Robbins, A., Kohler, B. & Jemal, A. Childhood and adolescent cancer statistics, 2014. CA: a cancer journal for clinicians 64, 83\u2013103 (2014).","journal-title":"CA: a cancer journal for clinicians"},{"issue":"5","key":"65825_CR6","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s40264-018-0760-1","volume":"42","author":"Anthony Stein","year":"2018","unstructured":"Stein, A. et al. Benefit-Risk Assessment of Blinatumomab in the Treatment of Relapsed\/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia. Drug safety; https:\/\/doi.org\/10.1007\/s40264-018-0760-1 (2018).","journal-title":"Drug Safety"},{"key":"65825_CR7","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.6004\/jnccn.2015.0153","volume":"13","author":"JC Alvarnas","year":"2015","unstructured":"Alvarnas, J. C. et al. Acute Lymphoblastic Leukemia, Version 2.2015. J Natl Compr Canc Netw 13, 1240\u20131279 (2015).","journal-title":"J Natl Compr Canc Netw"},{"key":"65825_CR8","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41568-018-0015-6","volume":"18","author":"M Greaves","year":"2018","unstructured":"Greaves, M. A causal mechanism for childhood acute lymphoblastic leukaemia. Nature reviews. Cancer 18, 471\u2013484 (2018).","journal-title":"Nature reviews. Cancer"},{"key":"65825_CR9","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1158\/0008-5472.CAN-03-2387","volume":"64","author":"S Zheng","year":"2004","unstructured":"Zheng, S. et al. Hypermethylation of the 5\u2032 CpG island of the FHIT gene is associated with hyperdiploid and translocation-negative subtypes of pediatric leukemia. Cancer research 64, 2000\u20132006 (2004).","journal-title":"Cancer research"},{"key":"65825_CR10","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1182\/blood.V95.6.1942","volume":"95","author":"IH Wong","year":"2000","unstructured":"Wong, I. H., Ng, M. H., Huang, D. P. & Lee, J. C. Aberrant p15 promoter methylation in adult and childhood acute leukemias of nearly all morphologic subtypes. Potential prognostic implications. Blood 95, 1942\u20131949 (2000).","journal-title":"Blood"},{"key":"65825_CR11","first-page":"97","volume":"12","author":"C Matsushita","year":"2004","unstructured":"Matsushita, C. et al. Aberrant methylation in promoter-associated CpG islands of multiple genes in relapsed childhood acute lymphoblastic leukemia. Oncology reports 12, 97\u201399 (2004).","journal-title":"Oncology reports"},{"key":"65825_CR12","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.12688\/f1000research.14634.1","volume":"7","author":"Kristie N Ramos","year":"2018","unstructured":"Ramos, K. N., Ramos, I. N., Zeng, Y. & Ramos, K. S. Genetics and epigenetics of pediatric leukemia in the era of precision medicine. F1000Research 7; https:\/\/doi.org\/10.12688\/f1000research.14634.1 (2018).","journal-title":"F1000Research"},{"key":"65825_CR13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0163-7827(94)00009-B","volume":"34","author":"O Ohara","year":"1995","unstructured":"Ohara, O., Ishizaki, J. & Arita, H. Structure and function of phospholipase A2 receptor. Progress in lipid research 34, 117\u2013138 (1995).","journal-title":"Progress in lipid research"},{"key":"65825_CR14","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/embor.2008.255","volume":"10","author":"A Augert","year":"2009","unstructured":"Augert, A. et al. The M-type receptor PLA2R regulates senescence through the p53 pathway. EMBO reports 10, 271\u2013277 (2009).","journal-title":"EMBO reports"},{"key":"65825_CR15","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.freeradbiomed.2013.08.177","volume":"65","author":"A Augert","year":"2013","unstructured":"Augert, A. et al. PLA2R1 kills cancer cells by inducing mitochondrial stress. Free radical biology & medicine 65, 969\u2013977 (2013).","journal-title":"Free radical biology & medicine"},{"key":"65825_CR16","doi-asserted-by":"publisher","first-page":"5033","DOI":"10.1038\/onc.2016.43","volume":"35","author":"A Griveau","year":"2016","unstructured":"Griveau, A. et al. The PLA2R1-JAK2 pathway upregulates ERR\u03b1 and its mitochondrial program to exert tumor-suppressive action. Oncogene 35, 5033\u20135042 (2016).","journal-title":"Oncogene"},{"key":"65825_CR17","doi-asserted-by":"publisher","first-page":"6334","DOI":"10.1158\/0008-5472.CAN-13-0318","volume":"73","author":"D Vindrieux","year":"2013","unstructured":"Vindrieux, D. et al. PLA2R1 mediates tumor suppression by activating JAK2. Cancer research 73, 6334\u20136345 (2013).","journal-title":"Cancer research"},{"key":"65825_CR18","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.semcancer.2017.11.002","volume":"56","author":"Olga Sukocheva","year":"2019","unstructured":"Sukocheva, O. et al. Current insights into functions of phospholipase A2 receptor in normal and cancer cells. More questions than answers. Seminars in cancer biology; https:\/\/doi.org\/10.1016\/j.semcancer.2017.11.002 (2017).","journal-title":"Seminars in Cancer Biology"},{"key":"65825_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-12-576","volume":"12","author":"M Menschikowski","year":"2012","unstructured":"Menschikowski, M. et al. Aberrant methylation of the M-type phospholipase A(2) receptor gene in leukemic cells. BMC cancer 12, 576 (2012).","journal-title":"BMC cancer"},{"key":"65825_CR20","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nri1330","volume":"4","author":"RT Abraham","year":"2004","unstructured":"Abraham, R. T. & Weiss, A. Jurkat T cells and development of the T-cell receptor signalling paradigm. Nature reviews. Immunology 4, 301\u2013308 (2004).","journal-title":"Nature reviews. Immunology"},{"key":"65825_CR21","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/ajh.20503","volume":"80","author":"CS Chim","year":"2005","unstructured":"Chim, C. S., Wong, A. S. Y. & Kwong, Y. L. Epigenetic inactivation of the CIP\/KIP cell-cycle control pathway in acute leukemias. American journal of hematology 80, 282\u2013287 (2005).","journal-title":"American journal of hematology"},{"key":"65825_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/1389202917666160803165447","volume":"18","author":"K Sak","year":"2017","unstructured":"Sak, K. & Everaus, H. Established Human Cell Lines as Models to Study Anti-leukemic Effects of Flavonoids. Current genomics 18, 3\u201326 (2017).","journal-title":"Current genomics"},{"key":"65825_CR23","doi-asserted-by":"publisher","first-page":"299","DOI":"10.21873\/cgp.20088","volume":"15","author":"M Menschikowski","year":"2018","unstructured":"Menschikowski, M. et al. Identification and Quantification of Heterogeneously-methylated DNA Fragments Using Epiallele-sensitive Droplet Digital Polymerase Chain Reaction (EAST-ddPCR). Cancer genomics & proteomics 15, 299\u2013312 (2018).","journal-title":"Cancer genomics & proteomics"},{"key":"65825_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2013-14-9-r105","volume":"14","author":"J Nordlund","year":"2013","unstructured":"Nordlund, J. et al. Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia. Genome biology 14, r105 (2013).","journal-title":"Genome biology"},{"key":"65825_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9489","volume":"6","author":"N Jung","year":"2015","unstructured":"Jung, N., Dai, B., Gentles, A. J., Majeti, R. & Feinberg, A. P. An LSC epigenetic signature is largely mutation independent and implicates the HOXA cluster in AML pathogenesis. Nature communications 6, 8489 (2015).","journal-title":"Nature communications"},{"key":"65825_CR26","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.4161\/epi.29315","volume":"9","author":"Y Qu","year":"2014","unstructured":"Qu, Y. et al. Differential methylation in CN-AML preferentially targets non-CGI regions and is dictated by DNMT3A mutational status and associated with predominant hypomethylation of HOX genes. Epigenetics 9, 1108\u20131119 (2014).","journal-title":"Epigenetics"},{"key":"65825_CR27","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.cell.2016.06.017","volume":"166","author":"F Iorio","year":"2016","unstructured":"Iorio, F. et al. A Landscape of Pharmacogenomic Interactions in Cancer. Cell 166, 740\u2013754 (2016).","journal-title":"Cell"},{"key":"65825_CR28","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nature11003","volume":"483","author":"J Barretina","year":"2012","unstructured":"Barretina, J. et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483, 603\u2013607 (2012).","journal-title":"Nature"},{"key":"65825_CR29","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1309\/AJCPO4DS0GTLSOEI","volume":"132","author":"NM Hassanein","year":"2009","unstructured":"Hassanein, N. M., Alcancia, F., Perkinson, K. R., Buckley, P. J. & Lagoo, A. S. Distinct expression patterns of CD123 and CD34 on normal bone marrow B-cell precursors (\u201chematogones\u201d) and B lymphoblastic leukemia blasts. American journal of clinical pathology 132, 573\u2013580 (2009).","journal-title":"American journal of clinical pathology"},{"key":"65825_CR30","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/cyto.b.20633","volume":"82","author":"MH Hoffmann","year":"2012","unstructured":"Hoffmann, M. H. et al. Clinical impact of leukemic blast heterogeneity at diagnosis in cytogenetic intermediate-risk acute myeloid leukemia. Cytometry. Part B, Clinical cytometry 82, 123\u2013131 (2012).","journal-title":"Cytometry. Part B, Clinical cytometry"},{"key":"65825_CR31","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1055\/s-2008-1046467","volume":"208","author":"G Baersch","year":"1996","unstructured":"Baersch, G. et al. Durchflusszytometrische Charakterisierung von Reifungsvorg\u00e4ngen und stammzellnahen Zellpopulationen bei der B-Vorl\u00e4uferzell-ALL im Kindesalter. Klinische Padiatrie 208, 160\u2013167 (1996).","journal-title":"Klinische Padiatrie"},{"key":"65825_CR32","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1182\/blood.V73.2.543.543","volume":"73","author":"TA Longacre","year":"1989","unstructured":"Longacre, T. A. et al. Hematogones: a multiparameter analysis of bone marrow precursor cells. Blood 73, 543\u2013552 (1989).","journal-title":"Blood"},{"key":"65825_CR33","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3389\/fped.2014.00042","volume":"2","author":"MJ Burke","year":"2014","unstructured":"Burke, M. J. & Bhatla, T. Epigenetic modifications in pediatric acute lymphoblastic leukemia. Frontiers in pediatrics 2, 42 (2014).","journal-title":"Frontiers in pediatrics"},{"key":"65825_CR34","doi-asserted-by":"publisher","first-page":"908","DOI":"10.3109\/10428194.2010.551160","volume":"52","author":"R Amin","year":"2011","unstructured":"Amin, R. et al. Phospholipase A2 receptors in human leukemic blasts. Leukemia & lymphoma 52, 908\u2013909 (2011).","journal-title":"Leukemia & lymphoma"},{"key":"65825_CR35","doi-asserted-by":"publisher","first-page":"35983","DOI":"10.18632\/oncotarget.26316","volume":"9","author":"M Friedemann","year":"2018","unstructured":"Friedemann, M. et al. Diverse effects of phospholipase A2 receptor expression on LNCaP and PC-3 prostate cancer cell growth in vitro and in vivo. Oncotarget 9, 35983\u201335996 (2018).","journal-title":"Oncotarget"},{"key":"65825_CR36","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","volume":"16","author":"SA Miller","year":"1988","unstructured":"Miller, S. A., Dykes, D. D. & Polesky, H. F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic acids research 16, 1215 (1988).","journal-title":"Nucleic acids research"},{"key":"65825_CR37","first-page":"e22","volume":"45","author":"W Zhou","year":"2017","unstructured":"Zhou, W., Laird, P. W. & Shen, H. Comprehensive characterization, annotation and innovative use of Infinium DNA methylation BeadChip probes. Nucleic acids research 45, e22 (2017).","journal-title":"Nucleic acids research"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-65825-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-65825-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-65825-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T11:54:44Z","timestamp":1670327684000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-65825-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,3]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["65825"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-65825-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,3]]},"assertion":[{"value":"20 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9058"}}